Literature DB >> 23535921

Priorities for improving drug research, development and regulation.

Susan R Forda1, Richard Bergström, Magda Chlebus, Richard Barker, Peter Høngaard Andersen.   

Abstract

Mesh：

Year:  2013        PMID： 23535921     DOI： 10.1038/nrd3981

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

1.  New horizons in pharmaceutical regulation.

Authors:  Alasdair Breckenridge; Michelle Mello; Bruce M Psaty
Journal:  Nat Rev Drug Discov       Date:  2012-06-29       Impact factor: 84.694

Review 2.  The future of drug development: advancing clinical trial design.

Authors:  John Orloff; Frank Douglas; Jose Pinheiro; Susan Levinson; Michael Branson; Pravin Chaturvedi; Ene Ette; Paul Gallo; Gigi Hirsch; Cyrus Mehta; Nitin Patel; Sameer Sabir; Stacy Springs; Donald Stanski; Matthias R Evers; Edd Fleming; Navjot Singh; Tony Tramontin; Howard Golub
Journal:  Nat Rev Drug Discov       Date:  2009-10-09       Impact factor: 84.694

3.  A call to reform the taxonomy of human disease.

Authors:  Ismail Kola; John Bell
Journal:  Nat Rev Drug Discov       Date:  2011-08-31       Impact factor: 84.694
  3 in total
  2 in total

Review 1.  European perspective for effective cancer drug development.

Authors:  Denis Lacombe; Sabine Tejpar; Roberto Salgado; Fatima Cardoso; Vassilis Golfinopoulos; Daniela Aust; Gunnar Folprecht; Arnaud Roth; Roger Stupp
Journal:  Nat Rev Clin Oncol       Date:  2014-06-17       Impact factor: 66.675

2.  Toward a Tiered Model to Share Clinical Trial Data and Samples in Precision Oncology.

Authors:  Stefanie Broes; Denis Lacombe; Michiel Verlinden; Isabelle Huys
Journal:  Front Med (Lausanne)       Date:  2018-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.